Search research articles
Contact Us
Filters
Showing results (141-150 of 212) with videos related to
Page
of 22
Sort By:
Acta Haematologica
|
April 19, 2013
B-lymphoblastic leukemia/lymphoma associated with t(8;13)(p11;q12)/ ZMYM2 (ZNF198)-FGFR1 : rare case and review of the literature
Janese Trimaldi, Estrella M Carballido, Jeremy W Bowers, et al.
Leukemia & Lymphoma
|
February 25, 2020
Comparison of mutational profiles and clinical outcomes in patients with acute myeloid leukemia with mutated <i>RUNX1</i> versus acute myeloid leukemia with myelodysplasia-related changes with mutated <i>RUNX1</i>
Lynh Nguyen, Xiaohui Zhang, Evans Roberts, et al.
American Journal of Hematology
|
October 24, 2012
Hypoalbuminemia is an independent prognostic factor for overall survival in myelodysplastic syndromes
Rami S Komrokji, Maria Corrales-Yepez, Mohamed A Kharfan-Dabaja, et al.
Blood
|
March 8, 2007
Reduced natural killer (NK) function associated with high-risk myelodysplastic syndrome (MDS) and reduced expression of activating NK receptors
Pearlie K Epling-Burnette, Fanqi Bai, Jeffrey S Painter, et al.
American Journal of Hematology
|
August 19, 2015
Comparing the prognostic value of risk stratifying models for patients with lower-risk myelodysplastic syndromes: Is one model better?
Amer M Zeidan, Mikkael A Sekeres, Xiao-Feng Wang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 11, 2009
Mutations of e3 ubiquitin ligase cbl family members constitute a novel common pathogenic lesion in myeloid malignancies
Hideki Makishima, Heather Cazzolli, Hadrian Szpurka, et al.
Cancer
|
September 3, 2011
A phase 2 randomized multicenter study of 2 extended dosing schedules of oral ezatiostat in low to intermediate-1 risk myelodysplastic syndrome
Azra Raza, Naomi Galili, Scott E Smith, et al.
Scientific Reports
|
March 29, 2020
Association of immunophenotype with expression of topoisomerase II α and β in adult acute myeloid leukemia
Andrew P Michelson, Shannon McDonough, Cheryl L Willman, et al.
Blood
|
February 3, 2011
Prognostic impact of SNP array karyotyping in myelodysplastic syndromes and related myeloid malignancies
Ramon V Tiu, Lukasz P Gondek, Christine L O'Keefe, et al.
Leukemia & Lymphoma
|
June 4, 2011
Telomere length in myelodysplastic syndromes
Dana E Rollison, P K Epling-Burnette, Jong Y Park, et al.
Page
of 22
Search research articles
Search
Showing results (141-150 of 212) with videos related to
Sort By:
Page
of 22
Acta Haematologica
|
April 19, 2013
B-lymphoblastic leukemia/lymphoma associated with t(8;13)(p11;q12)/ ZMYM2 (ZNF198)-FGFR1 : rare case and review of the literature
Janese Trimaldi, Estrella M Carballido, Jeremy W Bowers, et al.
Leukemia & Lymphoma
|
February 25, 2020
Comparison of mutational profiles and clinical outcomes in patients with acute myeloid leukemia with mutated <i>RUNX1</i> versus acute myeloid leukemia with myelodysplasia-related changes with mutated <i>RUNX1</i>
Lynh Nguyen, Xiaohui Zhang, Evans Roberts, et al.
American Journal of Hematology
|
October 24, 2012
Hypoalbuminemia is an independent prognostic factor for overall survival in myelodysplastic syndromes
Rami S Komrokji, Maria Corrales-Yepez, Mohamed A Kharfan-Dabaja, et al.
Blood
|
March 8, 2007
Reduced natural killer (NK) function associated with high-risk myelodysplastic syndrome (MDS) and reduced expression of activating NK receptors
Pearlie K Epling-Burnette, Fanqi Bai, Jeffrey S Painter, et al.
American Journal of Hematology
|
August 19, 2015
Comparing the prognostic value of risk stratifying models for patients with lower-risk myelodysplastic syndromes: Is one model better?
Amer M Zeidan, Mikkael A Sekeres, Xiao-Feng Wang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 11, 2009
Mutations of e3 ubiquitin ligase cbl family members constitute a novel common pathogenic lesion in myeloid malignancies
Hideki Makishima, Heather Cazzolli, Hadrian Szpurka, et al.
Cancer
|
September 3, 2011
A phase 2 randomized multicenter study of 2 extended dosing schedules of oral ezatiostat in low to intermediate-1 risk myelodysplastic syndrome
Azra Raza, Naomi Galili, Scott E Smith, et al.
Scientific Reports
|
March 29, 2020
Association of immunophenotype with expression of topoisomerase II α and β in adult acute myeloid leukemia
Andrew P Michelson, Shannon McDonough, Cheryl L Willman, et al.
Blood
|
February 3, 2011
Prognostic impact of SNP array karyotyping in myelodysplastic syndromes and related myeloid malignancies
Ramon V Tiu, Lukasz P Gondek, Christine L O'Keefe, et al.
Leukemia & Lymphoma
|
June 4, 2011
Telomere length in myelodysplastic syndromes
Dana E Rollison, P K Epling-Burnette, Jong Y Park, et al.
Page
of 22